Formic Acid

Formic Acid

SCHEMBL4160207

CNc1nccc(-c2ccc3[nH]c(=O)c4[nH]cc(CCC(=O)O)c4c3c2)n1.O=CO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.41
TTK P33981 2/20 0.41
AURKB Q96GD4 2/20 0.41
INCENP Q9NQS7 2/20 0.41
PDPK1 O15530 2/20 0.38
SRC P12931 1/20 0.36
FLT3 P36888 1/20 0.36
ITK Q08881 1/20 0.36
SPHK1 Q9NYA1 1/20 0.33
SYK P43405 3/20 0.33
PDK1 Q15118 1/20 0.33
MAPK13 O15264 1/20 0.33
RAF1 P04049 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
S1PR1 P21453 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4169945 0.97 AURKA (0.43) AURKATTKAURKBINCENPPDPK1
SCHEMBL4160215 0.89 AURKA (0.39) AURKATTKAURKBINCENPPDPK1
SCHEMBL4160172 0.88 PDPK1 (0.43) AURKATTKAURKBINCENPPDPK1
SCHEMBL4161175 0.86 CAMK2D (0.45) SPHK1SYK
Formic Acid SCHEMBL4159384 0.84 PIM1 (0.36) HPGDCYP2C19S1PR1
SCHEMBL4159498 0.84 PDPK1 (0.39) PDPK1HPGDCYP2C19S1PR1IKBKB
SCHEMBL4157705 0.83 HPGD (0.41) AURKAAURKBPDPK1SYKMAPK9
SCHEMBL4163761 0.83 AURKA (0.47) AURKATTKAURKBINCENPPDPK1
SCHEMBL4161856 0.82 ITGB3 (0.40) AURKATTKAURKBINCENPSPHK1
SCHEMBL3245619 0.81 AURKA (0.47) AURKATTKAURKBINCENPPDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 AURKA 512/4885TTK 229/4885AURKB 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.